Theron Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2008-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.theronpharma.com
Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics
- First Posted Date
- 2015-03-06
- Last Posted Date
- 2017-05-09
- Lead Sponsor
- Theron Pharmaceuticals, Inc.
- Target Recruit Count
- 59
- Registration Number
- NCT02382510
- Locations
- 🇺🇸
Sylvana Research, San Antonio, Texas, United States
🇺🇸WCCT Global, Costa Mesa, California, United States
🇺🇸Dr. Winder & Associates/Toledo Center for Clinical Research, Sylvania, Ohio, United States
Single Ascending Dose Study of TRN-157 in Healthy Subjects
Phase 1
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-05-08
- Last Posted Date
- 2014-10-31
- Lead Sponsor
- Theron Pharmaceuticals, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02133339
© Copyright 2025. All Rights Reserved by MedPath